Effects of carnitine supplementation on myocardial function and energy provision in experimental uraemia

Area of Science:

• Nephrology
• Cardiology
• Biochemistry

Background:

• Cardiovascular complications are the primary cause of mortality in chronic kidney disease (CKD).
• Uremia induces cardiac remodeling, metabolic dysfunction, and reduced myocardial energy reserves.
• Experimental uremia is linked to left ventricular hypertrophy and carnitine depletion.

Purpose of the Study:

• To investigate the impact of chronic L-carnitine supplementation on myocardial substrate metabolism and cardiac function in experimental uremia.
• To determine if L-carnitine can mitigate the cardiac changes associated with uremia.

Main Methods:

• Experimental uremia was induced in Sprague-Dawley rats via subtotal nephrectomy.
• L-carnitine was administered continuously using mini-osmotic pumps.
• Cardiac function and substrate oxidation were assessed using in vitro isovolumic perfusion and 13C NMR at 3 and 6 weeks.

Main Results:

• Uremic animals showed anemia, kidney dysfunction, and systemic carnitine deficiency, but not myocardial carnitine deficiency.
• L-carnitine supplementation abolished myocardial hypertrophy in uremic rats.
• This effect was associated with reduced myocardial glucose utilization, and was amplified with treatment duration.

Conclusions:

• Chronic L-carnitine supplementation effectively prevents cardiac hypertrophy in experimental uremia.
• The cardioprotective effect of L-carnitine is linked to altered myocardial substrate utilization, specifically reduced glucose use.
• L-carnitine supplementation did not significantly alter myocardial function despite preventing hypertrophy.